Sofosbuvir/velpatasvir improves patient-reported outcomes in HCV patients: results from ASTRAL-1 placebo-controlled trial

Younossi ZM, Stepanova M, Feld J, Zeuzem S, Jacobson I, Agarwal K, et al. Sofosbuvir/velpatasvir improves patient-reported outcomes in HCV patients: results from ASTRAL-1 placebo-controlled trial. J Hepatol. 2016;65(1):33-39.

Publication Type:

Journal Article

Authors:

Younossi, Zobair M.; Stepanova, Maria; Feld, Jordan; Zeuzem, Stefan; Jacobson, Ira; Agarwal, Kosh; Hezode, Christophe; Nader, Fatema; Henry, Linda; Hunt, Sharon

Source:

J Hepatol, Volume 65, Issue 1, p.33-39 (2016)

Keywords:

HCV, PRO, SOF/VEL

Cited On:

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/26956698

Export Citation:
RIS Format
Top